NIAGEN BIOSCIENCE ANNOUNCES FIRST-EVER PEER-REVIEWED STUDY HIGHLIGHTING THE POTENTIAL OF NICOTINAMIDE RIBOSIDE (NR) FOR WERNER SYNDROME, A RARE GENETIC DISORDER

Reuters · 06/09 12:32

Please log in to view news